Skip to main content

. 2022 Jun 16;162(7):S-596. doi: 10.1016/S0016-5085(22)61410-0

Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES

Keren M Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob Ollech, Lev Lichtenstein, Hagar Banai, Henit A Yanai, Yifat Snir, Maor HPauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Tsachi-Tsadok Perets, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Sophy Goren, Noy Krugliak, Michal Werbner, Joel Alter, Moshe Dessau, Meital Gal Tanamy, Daniel Cohen, Natalia T Freund, Iris Dotan

PMCID: PMC9212456

The content is available as a PDF (849.7 KB).

ACTIONS

RESOURCES